Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

Targeted Therapy (Antibody-Drug Conjugate) (13)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Sacituzumab Govitecan	ADC	Solid Tumour
Molecule Sacituzumab Govitecan Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Enfortumab Vedotin	ADC	Solid Tumour
Molecule Enfortumab Vedotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Tisotumab Vedotin	ADC	Solid Tumour
Molecule Tisotumab Vedotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Mirvetuximab Soravtansine	ADC	Solid Tumour
Molecule Mirvetuximab Soravtansine Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Datopotamab Deruxtecan	ADC	Solid Tumour
Molecule Datopotamab Deruxtecan Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Patritumab Deruxtecan	ADC	Solid Tumour
Molecule Patritumab Deruxtecan Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Rovalpituzumab Tesirine	ADC	Solid Tumour
Molecule Rovalpituzumab Tesirine Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Depatuxizumab Mafodotin	ADC	Solid Tumour
Molecule Depatuxizumab Mafodotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Telisotuzumab Vedotin	ADC	Solid Tumour
Molecule Telisotuzumab Vedotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Zilovertamab Vedotin	ADC	Solid Tumour
Molecule Zilovertamab Vedotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Ladiratuzumab Vedotin	ADC	Solid Tumour
Molecule Ladiratuzumab Vedotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Cofetuzumab Pelidotin	ADC	Solid Tumour
Molecule Cofetuzumab Pelidotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC

Sacituzumab Govitecan Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Enfortumab Vedotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Tisotumab Vedotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Mirvetuximab Soravtansine Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Datopotamab Deruxtecan Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Patritumab Deruxtecan Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Rovalpituzumab Tesirine Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Depatuxizumab Mafodotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Telisotuzumab Vedotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Zilovertamab Vedotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Ladiratuzumab Vedotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Cofetuzumab Pelidotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC

‹ 1 2 ›

Product Range

Company

Global Network

Products

Sacituzumab Govitecan

Enfortumab Vedotin

Tisotumab Vedotin

Mirvetuximab Soravtansine

Datopotamab Deruxtecan

Patritumab Deruxtecan

Rovalpituzumab Tesirine

Depatuxizumab Mafodotin

Telisotuzumab Vedotin

Zilovertamab Vedotin

Ladiratuzumab Vedotin

Cofetuzumab Pelidotin